About: Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $17.07 (-3.07%)
BCAX NASDAQ Bicara Therapeutics Inc. Common Stock
Bicara Therapeutics Inc. Common Stock share price
BCAX price activity
Last Price
$17.070
Change (24hr)
-0.54 USD (3.07%)
Volume
724.71K
Volume (4w avg)
-
Open
$17.53
Day Range
$16.98 - $17.85
Previous Close
$17.61
Last Trade
23 Oct, 8:00 pm GMT+0
Delayed
23 Oct, 8:00 pm GMT+0
BCAX price performance
Delayed
23 Oct, 8:00 pm GMT+0
BCAX Market Signals